| HSCT | Hematopoietic Stem Cell Transplantation |
| aGVHD | Acute Graft-versus-Host Disease |
| cGVHD | Chronic Graft-versus-Host Disease |
| GVHD | Graft-versus-Host Disease |
| APC | Antigen-Presenting Cell |
| Treg | Regulatory T cells |
| Th1 | T helper 1 cells |
| Th2 | T helper 2 cells |
| Th17 | T helper 17 cells |
| NK | Natural Killer cells |
| CMV | Cytomegalovirus |
| HLA | Human Leukocyte Antigen |
| 25(OH)D | 25-Hydroxyvitamin D |
| 1,25(OH)2D | 1,25-Dihydroxyvitamin D |
| VDR | Vitamin D Receptor |
| CYP27B1 | 1-alpha-hydroxylase |
| DEXA | Dual-Energy X-ray Absorptiometry |
| BMI | Body Mass Index |
| AML | Acute Myeloid Leukemia |
| ALL | Acute Lymphoblastic Leukemia |
| IU | International Units |
| GI-GVHD | Gastrointestinal Graft-versus-Host Disease |
| LC-MS/MS | Liquid Chromatography–Tandem Mass Spectrometry |
| CPOE | Computerized Provider Order Entry |
| LL-37 | Cathelicidin Antimicrobial Peptide |
| OS | Overall Survival |
| DFS | Disease-Free Survival |